Clinical Trial

Adaptive Optics Retinal Imaging

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to collect and assess adaptive optics (AO) retinal images from human subjects in support of projects to demonstrate, advance, and enhance clinical use of AO technology.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-05-06; most recent amendment 2026-05-06.
Trial Details
NCT Number NCT05370287
Lead Sponsor Food and Drug Administration (FDA)
Collaborators: University of Maryland, Baltimore
Conditions Glaucoma, Primary Open Angle
Enrollment 150 participants
Start Date 2018-01-22
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-08